Objective: To review the safety and efficacy of haemofiltration and pl
asmafiltration in children with severe sepsis. Design: Retrospective c
ase notes analysis. Setting: University Paediatric Intensive Care Unit
. Patients: All children admitted to the intensive care unit between N
ovember 1985 and May 1992 with a primary diagnosis of severe sepsis wh
o also received blood filtration therapy. Interventions: Continuous ha
emofiltration (HF) 18 patients; continuous haemofiltration and plasmaf
iltration (PF) 9 patients. Measurements and results: 27 children with
sepsis-induced MOSF, median age 26.6 months (range 0.33-185), median w
eight 12 kg (range 2.5-58), mean PRISM score 19.4 (SD 8.6), mean numbe
r of organs failing 2.78 (SD 0.9) received filtration for a median dur
ation of 36 hours (range 2-145). Eight (30%) survived (PIP 5/18, PF 3/
9). There was no significant difference in the demographic features be
tween the HF group and the PF group and no difference in mortality. Th
e two groups were pooled to assess the effect of commencement of filtr
ation on clinical wellbeing. Arterial blood gases, electrolytes, full
blood examination, ventilator settings and doses of inotropes were rec
orded immediately prior to commencement of filtration and 18 h after c
ommencement. Serum anion gap and osmolality were calculated using conv
entional formulae. There were no significant changes in the level of c
ardiorespiratory support, or biochemical markers of severity following
commencement of filtration. Platelet count fell 32% (p = 0.029) but n
o bleeding was encountered. No severe complications were observed duri
ng 1222 h of filtration. No bleeding or infection was observed at the
site of cannulation. One child developed haemodynamic instability foll
owing commencement of plasmafiltration necessitating abandonment of th
e procedure. Conclusion: Haemofiltration or plasmafiltration can be pe
rformed safely in children with severe sepsis but their effect on outc
ome remains unknown.